A NEW THERAPEUTIC MODALITY FOR DIAGNOSING AND TREATING DISEASE

Peptide therapeutics

Peptides are modular chains of amino acids that serve as natural ligands for many receptors in the body and offer attractive attributes for new drug discovery.   The ability to  create large  peptide diversity libraries offers the potential to develop novel therapeutics with high target affinity and specificity.  However, low in vivo stability and poor pharmacokinetics have greatly limited the application  of peptides in pharmaceutical development.   Lassogen aims to change this paradigm through a new class of remarkable peptides uncovered in nature.

Lasso peptides

Gifts from nature.  Lasso peptides are naturally produced by bacteria and possess a distinctive threaded lariat fold that offers a 3D array of functionality for engaging biological targets. This unique lasso structure engenders these systems with beneficial properties such as high stability (to proteases, low pH, and heat) and potent biological activities. Our new genome mining algorithms have been trained using machine learning and indicate that millions of diverse lasso peptides are likely to reside in nature - a veritable untapped goldmine of new activities and novel mechanisms of action for drug discovery and development. 

Linear peptides are strings of amino acids that are easily degraded in vivo

Bacteria convert linear peptides into highly stable, bioactive lasso peptides

  • Millions in nature

  • Unique 3D structure

  • Highly stable 

  • Evolvable scaffolds

  • Infinite lasso diversity

  • Ideal size and shape for receptor binding

Diverse lasso structures have translated into a wide range of mechanisms of action, including activity vs challenging G protein-coupled receptors (GPCRs).  Many therapeutic applications of lasso peptides can be envisioned.

Technology platform 

Lassogen’s cutting-edge platform integrates genomics, advanced synthetic biology, and AI-data analytics to enable accelerated discovery, optimization, and production of our novel lasso peptide-based therapeutics.  Our AI-driven algorithms mine genomic space and predict lasso biosynthesis pathway genes.  Cell-free biology rapidly converts lasso sequence data into molecules that can be screened.  Hits are optimized through lasso evolution methods. Lassos of interest are scaled for development through engineered fermentation strains.  

Key publications

Hegemann, J.D., et al., Lasso Peptides: An Intriguing Class of Bacterial Natural Products, Acc. Chem. Res., 2015, 48, 1909−1919.  doi: 10.1021/acs.accounts.5b00156

 

Tietz, J.I., et al., A new genome-mining tool redefines the lasso peptide biosynthetic landscape, Nature Chem Bio, 2017, 13, 470-478.  doi: 10.1038/nchembio.2319

 

DiCaprio, A.J., et al., Enzymatic Reconstitution and Biosynthetic Investigation of the Lasso Peptide Fusilassin, J. Am. Chem. Soc., 2019, 141, 290−297. doi: 10.1021/jacs.8b09928

Al Toma, R.S., et al., Site-Directed and Global Incorporation of Orthogonal and Isostructural Noncanonical Amino Acids into the Ribosomal Lasso Peptide Capistruin, ChemBioChem, 2015, 16, 503 – 509.  doi: 10.1002/cbic.201402558

 
 
 

© 2020 by Lassogen, Inc.

  • Black Twitter Icon
  • Black LinkedIn Icon